Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

0.55 

0.00 0.0%

as of Jul 01 '22

52 Week Range:

0.49 0.74


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Intermediate Products, Bulk Medicine, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings and organic fertilizers; holds trademarks; trades in pharmaceutical products; and engages in the food production activities. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) 0.55
0.49
0.78
growth rate -2.9% 16.8%
Earnings BIT 528.00
970.34
737.52
332.72
578.61
903.03
1,018.50
1,230.64
1,381.69
growth rate 83.8% -24.0% -54.9% 73.9% 56.1% 12.8% 20.8% 12.3%
Avg.PE -27.60
-27.60
-27.60
-27.60
-27.60
growth rate 0.0% 0.0% 0.0% 0.0%
ROA 0.95
1.15
0.27
3.58
0.62
-1.89
0.56
4.76
4.24
4.59
6.31
growth rate 21.1% -76.5% 1,225.9% -82.7% -100.0% 100.0% 750.0% -10.9% 8.3% 37.5%
ROE 1.98
2.87
0.75
10.24
1.65
-5.08
1.52
11.81
10.03
9.20
11.01
growth rate 45.0% -73.9% 1,265.3% -83.9% -100.0% 100.0% 677.0% -15.1% -8.3% 19.7%
ROIC 2.35
2.65
1.32
6.63
2.54
-1.02
2.49
8.47
7.41
6.73
8.81
growth rate 12.8% -50.2% 402.3% -61.7% -100.0% 100.0% 240.2% -12.5% -9.2% 30.9%
Cur. Ratio 1.03
0.75
0.66
0.74
0.68
0.85
1.20
1.03
1.35
1.69
1.53
growth rate -27.2% -12.0% 12.1% -8.1% 25.0% 41.2% -14.2% 31.1% 25.2% -9.5%
Quick Ratio 0.75
0.37
0.41
0.43
0.38
0.55
0.83
0.71
0.98
1.29
1.08
growth rate -50.7% 10.8% 4.9% -11.6% 44.7% 50.9% -14.5% 38.0% 31.6% -16.3%
Leverage 2.29
2.65
3.02
2.71
2.59
2.79
2.59
2.39
2.35
1.74
1.75
growth rate 15.7% 14.0% -10.3% -4.4% 7.7% -7.2% -7.7% -1.7% -26.0% 0.6%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 2,897.00
3,291.00
2,981.58
2,195.21
1,960.82
2,453.68
3,065.89
3,241.07
3,359.50
3,799.91
growth rate 13.6% -9.4% -26.4% -10.7% 25.1% 25.0% 5.7% 3.7% 13.1%
Acct.Payable 1,809.00
1,938.00
2,069.77
1,683.17
1,525.65
1,840.88
2,281.75
2,283.17
2,277.50
3,210.68
growth rate 7.1% 6.8% -18.7% -9.4% 20.7% 24.0% 0.1% -0.3% 41.0%
Cur.Assets 6,611.00
6,542.00
6,623.76
5,760.69
5,757.25
5,764.93
6,697.01
8,713.53
8,225.00
9,986.33
growth rate -1.0% 1.3% -13.0% -0.1% 0.1% 16.2% 30.1% -5.6% 21.4%
Total Assets 16,142.00
19,600.00
18,918.19
17,407.92
14,966.06
14,111.85
14,602.30
15,699.69
14,963.71
16,331.12
growth rate 21.4% -3.5% -8.0% -14.0% -5.7% 3.5% 7.5% -4.7% 9.1%
Cash 646.00
1,081.00
1,003.08
1,114.54
1,782.88
1,593.77
1,578.54
3,164.82
2,996.80
3,331.01
growth rate 67.3% -7.2% 11.1% 60.0% -10.6% -1.0% 100.5% -5.3% 11.2%
Inventory 1,814.00
1,272.00
1,417.89
1,415.11
963.79
1,173.08
1,464.66
1,575.24
1,428.50
2,004.03
growth rate -29.9% 11.5% -0.2% -31.9% 21.7% 24.9% 7.6% -9.3% 40.3%
Cur.Liabilities 8,855.00
9,863.00
8,914.14
8,458.01
6,725.63
4,789.32
6,515.20
6,458.87
4,859.86
6,535.25
growth rate 11.4% -9.6% -5.1% -20.5% -28.8% 36.0% -0.9% -24.8% 34.5%
Liabilities 10,047.00
13,118.00
11,949.07
10,689.29
9,618.57
8,670.08
8,480.26
9,027.90
6,351.88
6,991.21
growth rate 30.6% -8.9% -10.5% -10.0% -9.9% -2.2% 6.5% -29.6% 10.1%
LT Debt 601.00
1,496.00
1,458.54
912.70
1,998.78
3,317.51
1,583.32
2,423.02
1,307.08
221.21
growth rate 148.9% -2.5% -37.4% 119.0% 66.0% -52.3% 53.0% -46.1% -83.1%
Equity 6,969.12
6,718.63
5,347.49
5,441.77
6,122.04
6,671.79
8,613.91
9,340.49
growth rate -3.6% -20.4% 1.8% 12.5% 9.0% 29.1% 8.4%
Common Shares 1,418.00
1,513.00
1,627.00
1,627.00
1,627.00
1,627.00
1,627.00
15.35
15.36
17.18
17.13
growth rate 6.7% 7.5% 0.0% 0.0% 0.0% 0.0% -99.1% 0.1% 11.9% -0.3%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 2,740.00
2,046.00
691.72
722.89
402.82
458.12
511.62
431.40
530.76
482.17
growth rate -25.3% -66.2% 4.5% -44.3% 13.7% 11.7% -15.7% 23.0% -9.2%
Cash Dividends 84.44
84.44
84.44
84.44
98.38
128.14
220.85
growth rate 0.0% 0.0% 0.0% 16.5% 30.3% 72.4%
Cash From OA 591.00
1,479.00
1,750.41
1,809.55
1,074.46
769.95
1,213.24
1,801.18
1,567.83
1,542.55
growth rate 150.3% 18.4% 3.4% -40.6% -28.3% 57.6% 48.5% -13.0% -1.6%
FCF per Share 0.02
0.05
0.09
growth rate 25.7% 21.6%
FCF -556.00
-1,852.00
-443.00
419.00
869.00
746.00
296.00
658.00
1,352.00
1,032.00
1,055.00
growth rate 0.0% 0.0% 100.0% 107.4% -14.2% -60.3% 122.3% 105.5% -23.7% 2.2%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Sales 7,022.00
7,648.00
8,029.84
7,694.56
6,077.94
6,826.65
7,510.59
8,392.60
8,772.49
9,703.44
growth rate 8.9% 5.0% -4.2% -21.0% 12.3% 10.0% 11.7% 4.5% 10.6%
Op.Income 162.00
528.00
970.34
737.52
332.72
578.61
903.03
1,018.50
1,230.64
1,381.69
growth rate 225.9% 83.8% -24.0% -54.9% 73.9% 56.1% 12.8% 20.8% 12.3%
IBT 663.55
235.42
-137.47
68.95
793.88
841.65
882.33
1,202.65
growth rate -64.5% -100.0% 100.0% 1,051.4% 6.0% 4.8% 36.3%
Net Income 162.00
48.00
681.08
110.36
-272.36
81.76
682.93
641.76
702.99
988.10
growth rate -70.4% 1,318.9% -83.8% -100.0% 100.0% 735.3% -6.0% 9.5% 40.6%
EPS 0.06
0.09
0.02
0.33
0.06
-0.17
0.05
0.32
0.39
0.40
0.54
growth rate 50.0% -77.8% 1,550.0% -81.8% -100.0% 100.0% 540.0% 21.9% 2.6% 35.0%
Gross Profit 2,117.00
2,638.00
3,228.39
2,961.19
2,162.62
2,498.22
3,052.14
3,621.26
3,806.22
4,211.05
growth rate 24.6% 22.4% -8.3% -27.0% 15.5% 22.2% 18.7% 5.1% 10.6%

Quarterly Statements

Item Name Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Earnings BIT 326.27
348.33
348.33
342.51
342.51
growth rate 6.8% 0.0% -1.7% 0.0%
Balance Sheet Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Acct.Receivable 3,359.50
3,518.09
3,518.09
3,799.91
3,799.91
growth rate 4.7% 0.0% 8.0% 0.0%
Acct.Payable 2,277.50
2,598.78
2,598.78
3,210.68
3,210.68
growth rate 14.1% 0.0% 23.6% 0.0%
Cur.Assets 8,225.00
9,408.31
9,408.31
9,986.33
9,986.33
growth rate 14.4% 0.0% 6.1% 0.0%
Total Assets 14,963.71
15,849.93
15,849.93
16,331.12
16,331.12
growth rate 5.9% 0.0% 3.0% 0.0%
Cash 2,996.80
3,526.16
3,526.16
3,331.01
3,331.01
growth rate 17.7% 0.0% -5.5% 0.0%
Inventory 1,428.50
1,653.16
1,653.16
2,004.03
2,004.03
growth rate 15.7% 0.0% 21.2% 0.0%
Cur.Liabilities 4,859.86
5,644.93
5,644.93
6,535.25
6,535.25
growth rate 16.2% 0.0% 15.8% 0.0%
Liabilities 6,351.88
6,760.24
6,760.24
6,991.21
6,991.21
growth rate 6.4% 0.0% 3.4% 0.0%
LT Debt 1,302.51
907.18
907.18
221.21
221.21
growth rate -30.4% 0.0% -75.6% 0.0%
Equity 8,613.91
9,090.23
9,090.23
9,340.49
9,340.49
growth rate 5.5% 0.0% 2.8% 0.0%
Common Shares 17.18
17.18
17.18
17.13
17.13
growth rate 0.0% 0.0% -0.3% 0.0%
Cash Flow Statement Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Capital Expenditures 177.29
174.56
174.56
66.53
66.53
growth rate -1.5% 0.0% -61.9% 0.0%
Cash Dividends 64.07
110.42
110.42
110.42
110.42
growth rate 72.4% 0.0% 0.0% 0.0%
Cash From OA 443.65
432.78
432.78
338.49
338.49
growth rate -2.5% 0.0% -21.8% 0.0%
FCF 266.36
258.22
258.22
271.97
271.97
growth rate -3.1% 0.0% 5.3% 0.0%
Income Statement Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Sales 2,233.95
2,359.53
2,359.53
2,492.19
2,492.19
growth rate 5.6% 0.0% 5.6% 0.0%
Op.Income 326.27
348.33
348.33
342.51
342.51
growth rate 6.8% 0.0% -1.7% 0.0%
IBT 278.22
361.10
361.10
240.22
240.22
growth rate 29.8% 0.0% -33.5% 0.0%
Net Income 250.08
311.54
311.54
182.51
182.51
growth rate 24.6% 0.0% -41.4% 0.0%
Gross Profit 1,004.11
1,047.94
1,047.94
1,057.59
1,057.59
growth rate 4.4% 0.0% 0.9% 0.0%
R&D -81.38
101.58
101.58
-101.58
-101.58
growth rate 100.0% 0.0% -100.0% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (61.32)

YOY Growth Grade:

D (35.10)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 5.68 5.73
EPS / Growth 0.10

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 11.2%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 11.2% 11.2% 11.2%
Future PE 0.01 3.79 9.33
Future EPS 0.28 0.28 0.28
Value Price
MOS %
0.00
-99.9%
0.26
-52.9%
0.64
15.9%
MOS Price 0.00 0.13 0.32
IRT 4.28 4.28 4.28

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.